ContractOffer Letter Agreement • November 7th, 2019 • Eiger BioPharmaceuticals, Inc. • Biological products, (no disgnostic substances)
OFFER LETTER AGREEMENTOffer Letter Agreement • April 3rd, 2024 • TJX Companies Inc /De/ • Retail-family clothing stores
AMENDMENT TO OFFER LETTER AGREEMENTOffer Letter Agreement • April 16th, 2010 • Amyris Biotechnologies Inc
This Amendment to the Offer Letter Agreement (this “Amendment”) is made and entered into as of December 18, 2008, by and among Jeff Lievense (“Executive”) and Amyris Biotechnologies, Inc., a California corporation (the “Company”).
AmpliPhi Biosciences Corporation Amendment to Offer Letter AgreementOffer Letter Agreement • April 4th, 2017 • AmpliPhi Biosciences Corp • Biological products, (no disgnostic substances) • California
This Amendment to Offer Letter Agreement (this “Amendment”) is entered into by and between AmpliPhi Biosciences Corporation (the “Company”) and Steve R. Martin (hereinafter “Employee”) effective as of April 1, 2017 (the “Effective Date”), and as of the Effective Date amends the terms of the Offer Letter Agreement entered into by and between the Company and Employee dated January 18, 2016 (the “Agreement”).
Opendoor Labs Inc.Offer Letter Agreement • November 27th, 2020 • Social Capital Hedosophia Holdings Corp. II • Real estate agents & managers (for others)
As discussed, you and Opendoor Labs Inc. (the “Company”) hereby agree to amend the offer letter agreement between you and the Company, dated July 22, 2019 (the “Offer Letter”), by adding to it the following provisions set forth below (the “Amendment”):
FIRST AMENDMENT TO OFFER LETTER AGREEMENTOffer Letter Agreement • May 16th, 2006 • Thoratec Corp • Electromedical & electrotherapeutic apparatus
This First Amendment to Offer Letter Agreement (the “Amendment”), made as of this 12th day of May, 2006, is entered into by and between Thoratec Corporation, a California corporation (the “Company”), and Cynthia Lucchese (“Employee”).
AmpliPhi Biosciences Corporation Amendment to Offer Letter AgreementOffer Letter Agreement • April 4th, 2017 • AmpliPhi Biosciences Corp • Biological products, (no disgnostic substances) • California
This Amendment to Offer Letter Agreement (this “Amendment”) is entered into by and between AmpliPhi Biosciences Corporation (the “Company”) and M. Scott Salka (hereinafter “Employee”) effective as of April 1, 2017 (the “Effective Date”), and as of the Effective Date amends the terms of the Offer Letter Agreement entered into by and between the Company and Employee dated April 24, 2015 (the “Agreement”).
SECOND AMENDMENT TO OFFER LETTER AGREEMENTOffer Letter Agreement • March 15th, 2021 • GENTHERM Inc • Motor vehicle parts & accessories
This SECOND AMENDMENT TO OFFER LETTER AGREEMENT (this “Amendment”) is made and entered into as of March 12, 2021, by and between Matteo Anversa (“Executive” or “you”) and Gentherm Incorporated (“Gentherm” or the “Company”). Executive and Gentherm are referred to herein each as a “Party” and, collectively, as the “Parties.”
Amendment to January 29, 2016 Employment Offer Letter AgreementOffer Letter Agreement • March 9th, 2017 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances)
This Amendment to Employment Agreement (“Amendment”) is between Amber Salzman, Ph.D. and Adverum Biotechnologies, Inc. (formerly Avalanche Biotechnologies, Inc.) (the “Company,” and together with Dr. Salzman, the “Parties”). Dr. Salzman will be assuming the position of Chief Executive Officer of the Company, and this Amendment sets forth the new terms of employment agreed upon by the Parties with respect to Dr. Salzman’s new position. The Parties intend this Amendment to amend and, to the extent it is inconsistent with, supersede Dr. Salzman’s prior Employment Offer Letter Agreement (“Employment Agreement”), dated January 29, 2016. To the extent it is not superseded, the Employment Agreement, including the attachments and agreements referenced in it, will remain in full force and effect.
AMENDMENT TO AMENDED AND RESTATED OFFER LETTER AGREEMENTOffer Letter Agreement • April 18th, 2016 • Phaserx, Inc. • Pharmaceutical preparations
This Amendment to Amended and Restated Offer Letter Agreement (this “Amendment”) is made and entered into as of the 13th day of March, 2016, by and between PhaseRx, Inc., a Delaware corporation, having a place of business at 410 West Harrison Street, Seattle, WA 98119 (the “Company”), and Robert W. Overell, Ph.D., having a place of business at 1854 NW 195th St. #302, Shoreline, WA 98177 (the “Executive”).
AMENDMENT TO OFFER LETTER AGREEMENTOffer Letter Agreement • May 8th, 2012 • Augme Technologies, Inc. • Communications equipment, nec
The OFFER LETTER AGREEMENT, (the “Agreement”) dated August 12, 2010, by and between Augme Technologies, Inc., a Delaware corporation, with its principal office at 43 W. 24th Street, 11th Floor, New York, NY 10010, (the “Company”) and Phillip Rapp, Jr., (“Employee”) is hereby amended as follows with the remaining provisions of the Agreement remaining in full force and effect.
FIRST AMENDMENT TO OFFER LETTER AGREEMENTOffer Letter Agreement • May 30th, 2024 • Rubicon Technologies, Inc. • Services-prepackaged software
This Amendment to the Offer Letter Agreement (hereinafter the “Amendment”) is made and entered into by and between Rubicon Technologies, Inc. (the “Company” or “Rubicon”), and Grant Deans (“Executive”), as of the date that the last party executes this Amendment (the “Effective Date”). This Amendment amends that certain Offer Letter Agreement entered into between the Company and Executive dated August 29, 2023 (the “Original Agreement”). The Company and Executive may be referred to in this Amendment individually as a “Party” and collectively as the “Parties”.
AMENDMENT No. 2 TO OFFER LETTER AGREEMENTOffer Letter Agreement • September 22nd, 2022 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
This AMENDMENT NO. 2 TO OFFER LETTER AGREEMENT (the “Amendment”) is effective as of September 18, 2022 (“Amendment Effective Date”), by and between BRAINSTORM CELL THERAPEUTICS INC., a Delaware corporation with a mailing address of 1325 Avenue of Americas, 28th Floor New York, NY 10019(the “Company”), and DR. STACY LINDBORG, an individual, with a mailing address of (the “Executive”).
First Amendment to Offer Letter AgreementOffer Letter Agreement • February 11th, 2022 • Porch Group, Inc. • Services-prepackaged software • Washington
This First Amendment to Offer Letter Agreement (the “Amendment”) is made and entered into as of February 11, 2022, by and between Porch.com, Inc. (the “Company”) and Martin Heimbigner (“Executive” or “you”). Executive and the Company are referred to herein each as a “Party” and, collectively, as the “Parties.” Capitalized terms used but not defined herein shall have the meanings given them in the Agreement (defined below).
OFFER LETTER AGREEMENT WITH SOMESH SINGHOffer Letter Agreement • March 11th, 2008 • Vignette Corp • Services-prepackaged software
AMENDMENT TO OFFER LETTER AGREEMENTOffer Letter Agreement • March 14th, 2024 • NCR VOYIX Corp • Calculating & accounting machines (no electronic computers)
This Amendment (“Amendment”) to that certain Offer Letter Agreement (the “Agreement”) dated June 9, 2023, by and between NCR Voyix Corporation (formerly NCR Corporation), a Maryland corporation (the “Company”), and Brian Webb-Walsh (“Executive”), is made and entered into effective as of March 13, 2024 (the “Effective Date”).
Curis Letterhead]Offer Letter Agreement • October 28th, 2008 • Curis Inc • Biological products, (no disgnostic substances)
Reference is hereby made to the Offer Letter Agreement, dated December 10, 2003, by and between Curis, Inc. (“Curis”) and you (the “Offer Letter”) as amended by the Amendment to Offer Letter, dated as of October 31, 2006, by and between Curis and you (the “Amendment”, and, together with the Offer Letter, the “Amended Offer Letter”).
October 21, 2016 Re:Amended and Restated Employment Agreement Dear Meenu:Offer Letter Agreement • November 10th, 2016 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
The Board of Directors has recently reviewed the terms and conditions of your employment and is pleased to provide this amended and restated letter agreement (the “Agreement”) modifying the terms of your employment in your continuing role as President and Chief Executive Officer of Proteostasis Therapeutics, Inc. (“Proteostasis” or the “Company”). This Agreement amends, restates, and supersedes in its entirety the letter agreement dated April 4, 2014 between you and the Company (the “Offer Letter Agreement”) and the letter agreement dated March 10, 2016. This Agreement is effective as of the date hereof.
Re: Amendment to October 31, 2008 Employment Offer Letter AgreementOffer Letter Agreement • March 7th, 2012 • Ipass Inc • Services-computer processing & data preparation
As you know, on October 31, 2008, you and iPass Inc. (the “Company”) entered into an Employment Offer Letter Agreement (the “Employment Agreement”). This letter agreement (the “Amendment”) modifies the Employment Agreement as follows:
SECOND AMENDMENT TO OFFER LETTER AGREEMENTOffer Letter Agreement • April 2nd, 2007 • Thoratec Corp • Electromedical & electrotherapeutic apparatus
This Second Amendment to Offer Letter Agreement (this “Second Amendment”), made as of this 1st day of December, 2006, is entered into by and between Thoratec Corporation, a California corporation (the “Company”), and Cynthia Lucchese (“Employee”).
May 30, 2019 Kenneth Burdick Dear Kenneth:Offer Letter Agreement • February 22nd, 2021 • Centene Corp • Hospital & medical service plans • Missouri
Upon, and subject to, the closing of the transactions contemplated by that certain Agreement and Plan of Merger, dated as of March 26, 2019 (the "Merger Agreement") made and entered into by Centene Corporation, WellCare Health Plans, Inc., d/b/a WellCare ("WellCare"), and certain other parties thereto, Centene Management Corporation ("Centene") shall employ you on the following terms set forth in this letter agreement (the "Agreement"):
ContractOffer Letter Agreement • March 10th, 2016 • OncoMed Pharmaceuticals Inc • Pharmaceutical preparations • California
October 12, 2015 Mr. Paul Hastings 61 Hartford Street San Francisco, CA 94114 Re: Change in Control and Severance Agreement Dear Paul: You and OncoMed Pharmaceuticals, Inc. (the “Company”) are parties to an offer letter dated November 12, 2005, as amended by the Amendment to Employment Agreement dated July 2, 2013 (the “Offer Letter Agreement”), which sets forth, among other things, the terms and conditions of certain severance benefits payable to you in the event of a qualifying termination of your employment. This letter (this “Agreement”) provides you with additional benefits in the event of certain terminations of your employment. This Agreement supersedes the change in control and severance provisions of your Offer Letter Agreement and any other agreement or policy to which the Company is a party with respect to the cessation of your employment with the Company. All other provisions of your Offer Letter Agreement shall remain in full force and effect. 1. Definitions. For purposes
AMENDMENT No. 3 TO OFFER LETTER AGREEMENTOffer Letter Agreement • January 4th, 2023 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances)
This AMENDMENT NO. 3 TO OFFER LETTER AGREEMENT (the “Amendment”) is effective as of the date on which the last party executes this Amendment (“Amendment Effective Date”), by and between BRAINSTORM CELL THERAPEUTICS INC., a Delaware corporation with a mailing address of 1325 Avenue of Americas, 28th Floor New York, NY 10019 (the “Company”), and DR. STACY LINDBORG, an individual (the “Executive”).
AMENDMENT TO OFFER LETTER AGREEMENTOffer Letter Agreement • April 16th, 2010 • Amyris Biotechnologies Inc
This Amendment to the Offer Letter Agreement (this “Amendment”) is made and entered into as of December 18, 2008, by and among John G. Melo (“Executive”) and Amyris Biotechnologies, Inc., a California corporation (the “Company”).
AGREEMENT TERMINATING THE RIGHT OF FIRST OFFER LETTER AGREEMENT This AGREEMENT TERMINATING THE RIGHT OF FIRST OFFER LETTER AGREEMENT is dated as of December 21, 2000 (this "Agreement"), by and among WHWEL Real Estate Limited Partnership, a Delaware...Offer Letter Agreement • December 22nd, 2000 • Whwel Real Estate Lp • Real estate investment trusts • New York
This AGREEMENT TERMINATING THE RIGHT OF FIRST OFFER LETTER AGREEMENT is dated as of December 21, 2000 (this "Agreement"), by and among WHWEL Real Estate Limited Partnership, a Delaware limited partnership ("WHWEL"), WXI/WWG Realty, L.L.C., a Delaware limited liability company ("WWG Realty"), W/W Group Holdings, L.L.C., a Delaware limited liability company ("W/W Group"), Wellsford Commercial Properties Trust, a Maryland real estate investment trust ("WCPT"), and Wellsford Real Properties, Inc., a Maryland corporation ("WRP").
AMENDMENT TO OFFER LETTER AGREEMENTOffer Letter Agreement • April 16th, 2010 • Amyris Biotechnologies Inc
This Amendment to the Offer Letter Agreement (this “Amendment”) is made and entered into as of December 19, 2008, by and among Joel R. Cherry (“Executive”) and Amyris Biotechnologies, Inc., a California corporation (the “Company”).
October 1, 2014Offer Letter Agreement • October 7th, 2014 • Regional Management Corp. • Personal credit institutions
FIRST AMENDMENT TO OFFER LETTER AGREEMENTOffer Letter Agreement • August 4th, 2020 • GENTHERM Inc • Motor vehicle parts & accessories
This FIRST AMENDMENT TO OFFER LETTER AGREEMENT (this “Amendment”) is made and entered into as of April 21, 2020, by and between Matteo Anversa (“Anversa” or “you”) and Gentherm Incorporated (“Gentherm” or the “Company”). Anversa and Gentherm are referred to herein each as a “Party” and, collectively, as the “Parties.”
First Amendment to Chairman of the Board of Directors Offer Letter AgreementOffer Letter Agreement • April 8th, 2015 • Car Charging Group, Inc. • Power, distribution & specialty transformers
This is the First Amendment (this “Amendment”) to that certain Chairman of the Board of Directors Offer Letter Agreement dated December 6, 2012 (the “Agreement”) by and between Car Charging Group, Inc. (the “Company”) and Governor Bill Richardson (“Richardson”).
Offer letter agreement between John Boutsikaris and Adept Technology, Inc. dated October 14, 2011Offer Letter Agreement • November 14th, 2011 • Adept Technology Inc • Special industry machinery, nec
On behalf of Adept Technology, Inc., I am pleased to offer you the position of Senior Vice President of Global Sales & Marketing, reporting to John Dulchinos, President & Chief Executive Officer. Your bi-weekly rate will be $8,462, which when annualized is a base salary of $220,000, subject to applicable taxes.
Mr. Michael Schradle 15069 Lynn Avenue Los Gatos, CA 95032 Dear Michael,Offer Letter Agreement • November 13th, 2012 • Adept Technology Inc • Special industry machinery, nec
On behalf of Adept Technology, Inc., I am pleased to offer you the position of Senior Vice President of Finance and Chief Financial Officer, reporting to John Dulchinos, President & Chief Executive Officer. Your bi-weekly rate will be $8,462, which when annualized is a base salary of $220,000, subject to applicable taxes.
AMENDMENT TO OFFER LETTER AGREEMENTOffer Letter Agreement • February 25th, 2009 • Gen Probe Inc • Surgical & medical instruments & apparatus • California
This Amendment to Offer Letter Agreement (the “Amendment”) is entered into as of October 31, 2008 (the “Effective Date”), between Christina Yang and Gen-Probe Incorporated, a Delaware corporation (“Gen-Probe”).
FIRST AMENDMENT TO OFFER LETTER AGREEMENTOffer Letter Agreement • January 29th, 2024 • Fractyl Health, Inc. • Surgical & medical instruments & apparatus
THIS FIRST AMENDMENT TO OFFER LETTER AGREEMENT (this “Amendment”) is entered into by and between Fractyl Health, Inc. (the “Company”) and Tim Kieffer (the “Executive”) and will become effective, if at all, as of the date of the Company’s initial public offering of stock (“IPO”) pursuant to an effective registration statement filed under the Securities Act of 1933 (the “Amendment Effective Date”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to them in the Offer Letter Agreement (as defined below).
ContractOffer Letter Agreement • January 3rd, 2011 • Apac Customer Services, Inc • Services-business services, nec • Illinois
This letter (the “Amendment”) sets forth the terms of your resignation as an officer of APAC Customer Services, Inc. (the “Company”). The Company and you entered into an Offer Letter Agreement dated as of April 1, 2010 (“Offer Letter”). Any capitalized term not defined in this Amendment has the meaning defined in the Offer Letter as applies.
